Empowered Funds LLC acquired a new stake in Maximus, Inc. (NYSE:MMS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 109,023 shares of the health services provider’s stock, valued at approximately $8,139,000. Empowered Funds LLC owned approximately 0.18% of Maximus at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of MMS. V Square Quantitative Management LLC acquired a new stake in shares of Maximus during the 3rd quarter valued at $25,000. UMB Bank n.a. raised its position in Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank acquired a new stake in shares of Maximus in the fourth quarter valued at about $29,000. R Squared Ltd bought a new stake in Maximus in the fourth quarter valued at approximately $54,000. Finally, GAMMA Investing LLC lifted its position in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock worth $80,000 after purchasing an additional 518 shares during the period. Institutional investors own 97.21% of the company’s stock.
Insider Activity
In other news, CEO Bruce Caswell acquired 3,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The stock was purchased at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michelle F. Link sold 2,208 shares of Maximus stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the transaction, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders bought 7,063 shares of company stock worth $502,017. 1.60% of the stock is owned by company insiders.
Analyst Ratings Changes
Get Our Latest Research Report on Maximus
Maximus Stock Down 0.1 %
Maximus stock opened at $69.75 on Tuesday. Maximus, Inc. has a fifty-two week low of $68.15 and a fifty-two week high of $93.97. The firm’s 50-day simple moving average is $74.64 and its 200 day simple moving average is $83.12. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.49 and a current ratio of 1.72. The stock has a market cap of $3.98 billion, a PE ratio of 15.00 and a beta of 0.72.
Maximus (NYSE:MMS – Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts predict that Maximus, Inc. will post 6.05 EPS for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date is Friday, February 14th. Maximus’s payout ratio is presently 25.81%.
Maximus Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Pros And Cons Of Monthly Dividend Stocks
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What Makes a Stock a Good Dividend Stock?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.